Last reviewed · How we verify

Duration of anticoagulation

British Thoracic Society · FDA-approved active Small molecule Quality 2/100

Duration of anticoagulation is a Small molecule drug developed by British Thoracic Society. It is currently FDA-approved.

At a glance

Generic nameDuration of anticoagulation
SponsorBritish Thoracic Society
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Duration of anticoagulation

What is Duration of anticoagulation?

Duration of anticoagulation is a Small molecule drug developed by British Thoracic Society.

Who makes Duration of anticoagulation?

Duration of anticoagulation is developed and marketed by British Thoracic Society (see full British Thoracic Society pipeline at /company/british-thoracic-society).

What development phase is Duration of anticoagulation in?

Duration of anticoagulation is FDA-approved (marketed).

Related